Skip to main content
The Society of Thoracic Surgeons

User account menu

  • Log in
Menu

Main navigation

  • FIGHT
    • Coping with Cancer
      • Just Diagnosed
      • In Treatment
      • In Remission
      • Survivorship
    • Cancer Information
      • Bladder Cancer
      • Blood Cancer
      • Breast Cancer
      • Head and Neck Cancer
      • Lung Cancer
      • Melanoma
      • Other
      • Latest Featured Content
      • The Archives
      • Other Resources
    • Find Clinical Trials
    • Glossary
      • Cancer FAQs
  • EDUCATE
    • Current Patient Education Video Series
      • Coronavirus and Covid 19 in the Cancer Community
      • Cancer Information for the Latino Community
      • 2020-21 Patient Education Ambassador's Program
      • Clinical Trials Experiences Through Storytelling
    • GRACE Podcasts
    • Video Library
      • English
      • Spanish
      • Mandarin
  • PARTICIPATE
    • Community Forum
      • Bladder Cancer
      • Blood Cancer
      • Brain Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Gall Bladder and Bile Duct Cancer (Cholangiocarcinoma)
      • Head and Neck Cancer
      • Kidney Cancer
      • Lung Cancer
      • Melanoma
      • Member Updates
      • General Forums
      • Ask A Question
    • Get Involved
      • Memorials and Tributes
      • Volunteer Opportunities
  • ABOUT CancerGRACE
    • GRACE NEWS AND INFO
      • Contact Us
      • How (and Why) to Use GRACE
      • GRACE Public Disclosure Documentation
    • About GRACE
      • Mission
      • Opportunities
      • Terms of Use
      • Our Supporters 2020
    • Our Team
      • Faculty
      • Staff and Board
    • Partnerships
      • GRACE and Clinical Care Options Patient Tools
      • Varian Partner Page 2020
      • Takeda Oncology Partnership Page 2020
      • Lilly Oncology Partner Page
  • DONATE
    • Why Give to GRACE
      • More Ways to Give
      • Corporate Giving Programs
      • Gifts of Stock or Securities
      • Shop and Search for the Cause
      • Create a Tribute
      • Create Your Own Fundraiser
      • Shop with GRACE

Breadcrumb

  1. Home
  2. Forums
  3. Squamous IIIB/IV, chemo+rad not an option, what is the standard of care? - 1293486

Panel Q&A Session on Acquired Resistance with Drs. Reckamp & Owonikoko

Article

Dr. West moderates a question & answer session with Drs. Karen Reckamp and Taofeek Owonikoko on issues of acquired resistance to targeted therapies for patients with advanced NSCLC that harbors a driver mutation.

  • Read more about Panel Q&A Session on Acquired Resistance with Drs. Reckamp & Owonikoko

What is Acquired Resistance to Targeted Therapy, and Why Does it Occur?

Article

Dr. Karen Reckamp of City of Hope Cancer Center reviews the concept of acquired resistance to targeted therapies in patients with a driver mutation and why it occurs.

  • Read more about What is Acquired Resistance to Targeted Therapy, and Why Does it Occur?

Dr. Karen Reckamp on "Which patients do you send molecular marker testing for, and what tests do you seek?"

Article

Dr. Karen Reckamp from City of Hope Cancer Center in Duarte, CA describes which patients with advanced NSCLC she seeks molecular marker testing on, and the particular markers she prioritizes.

[powerpress]

  • Read more about Dr. Karen Reckamp on "Which patients do you send molecular marker testing for, and what tests do you seek?"

Dr. Karen Reckamp: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?

Article

Dr. Karen Reckamp, City of Hope Cancer Center, provides her perspective on the likelihood that molecular oncology principles and targeted therapies will become more broadly applicable for patients with squamous and other lung cancer subtypes.

[powerpress]

  • Read more about Dr. Karen Reckamp: Will Our Gains in Targeted Therapies Be Generalizable to a Wider Range of Lung Cancers?

Dr. Karen Reckamp: Recommending a Repeat Biopsy, at Initial Diagnosis or with Acquired Resistance to a Targeted Therapy

Article

Dr. Karen Reckamp, City of Hope Cancer Center, reviews her thought process in recommending a repeat biopsy at initial diagnosis or after progression for patients with advanced lung cancer.

[powerpress]

  • Read more about Dr. Karen Reckamp: Recommending a Repeat Biopsy, at Initial Diagnosis or with Acquired Resistance to a Targeted Therapy
  • 10 comments
Subscribe to Karen Reckamp

Stay In touch

NEWSLETTER SIGN UP

MISSIONDONATEDISCLAIMERRESOURCES

Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock

  • Log in
  • FIGHT
    • Coping with Cancer
      • Just Diagnosed
      • In Treatment
      • In Remission
      • Survivorship
    • Cancer Information
      • Bladder Cancer
      • Blood Cancer
      • Breast Cancer
      • Head and Neck Cancer
      • Lung Cancer
      • Melanoma
      • Other
      • Latest Featured Content
      • The Archives
      • Other Resources
    • Find Clinical Trials
    • Glossary
      • Cancer FAQs
  • EDUCATE
    • Current Patient Education Video Series
      • Coronavirus and Covid 19 in the Cancer Community
      • Cancer Information for the Latino Community
      • 2020-21 Patient Education Ambassador's Program
      • Clinical Trials Experiences Through Storytelling
    • GRACE Podcasts
    • Video Library
      • English
      • Spanish
      • Mandarin
  • PARTICIPATE
    • Community Forum
      • Bladder Cancer
      • Blood Cancer
      • Brain Cancer
      • Breast Cancer
      • Colorectal Cancer
      • Gall Bladder and Bile Duct Cancer (Cholangiocarcinoma)
      • Head and Neck Cancer
      • Kidney Cancer
      • Lung Cancer
      • Melanoma
      • Member Updates
      • General Forums
      • Ask A Question
    • Get Involved
      • Memorials and Tributes
      • Volunteer Opportunities
  • ABOUT CancerGRACE
    • GRACE NEWS AND INFO
      • Contact Us
      • How (and Why) to Use GRACE
      • GRACE Public Disclosure Documentation
    • About GRACE
      • Mission
      • Opportunities
      • Terms of Use
      • Our Supporters 2020
    • Our Team
      • Faculty
      • Staff and Board
    • Partnerships
      • GRACE and Clinical Care Options Patient Tools
      • Varian Partner Page 2020
      • Takeda Oncology Partnership Page 2020
      • Lilly Oncology Partner Page
  • DONATE
    • Why Give to GRACE
      • More Ways to Give
      • Corporate Giving Programs
      • Gifts of Stock or Securities
      • Shop and Search for the Cause
      • Create a Tribute
      • Create Your Own Fundraiser
      • Shop with GRACE